Glucotrack, Inc. financial data

Symbol
GCTK on Nasdaq
Location
Rutherford, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 288% % 311%
Debt-to-equity 774% %
Return On Equity -2,655.78% % -266.44%
Return On Assets -303.77% % 57%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 910,688 shares -84.22%
Common Stock, Shares, Outstanding 899,410 shares -84.42%
Entity Public Float $8,600,000 USD 60%
Common Stock, Value, Issued $1,000 USD -83.33%
Weighted Average Number of Shares Outstanding, Basic 899,410 shares -80.71%
Weighted Average Number of Shares Outstanding, Diluted 899,410 shares -80.71%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $9,885,000 USD 3.6%
Selling and Marketing Expense $128,000 USD 83%
General and Administrative Expense $6,044,000 USD 92%
Operating Income (Loss) $-16,457,000 USD -25.53%
Net Income (Loss) Attributable to Parent $-25,854,000 USD -73.34%
Earnings Per Share, Basic -1,982 USD/shares
Earnings Per Share, Diluted -1,982 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $7,869,000 USD 2,174%
Other Assets, Current $237,000 USD -19.93%
Assets, Current $8,106,000 USD 1,163%
Property, Plant and Equipment, Net $144,000 USD 32%
Operating Lease, Right-of-Use Asset $40,000 USD -38.46%
Assets $8,290,000 USD 904%
Accounts Payable, Current $1,709,000 USD -7.97%
Liabilities, Current $5,297,000 USD 15%
Operating Lease, Liability, Noncurrent $12,000 USD -70%
Other Liabilities, Noncurrent $203,000 USD 3.6%
Liabilities $5,539,000 USD 14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $42,000 USD 740%
Retained Earnings (Accumulated Deficit) $-148,210,000 USD -21.13%
Stockholders' Equity Attributable to Parent $2,751,000 USD
Liabilities and Equity $8,290,000 USD 904%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $-2,939,000 USD 0.1%
Net Cash Provided by (Used in) Financing Activities $6,395,000 USD
Net Cash Provided by (Used in) Investing Activities $-9,000 USD 85%
Common Stock, Shares Authorized 250,000,000 shares 150%
Common Stock, Shares, Issued 899,410 shares -84.42%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,483,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5,627,000 USD 25%
Interest Paid, Excluding Capitalized Interest, Operating Activities $4,000 USD -85.71%
Deferred Tax Assets, Gross $20,465,000 USD 52%
Operating Lease, Liability $59,000 USD
Payments to Acquire Property, Plant, and Equipment $9,000 USD -84.75%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $-25,746,000 USD -72.28%
Lessee, Operating Lease, Liability, to be Paid $65,000 USD
Operating Lease, Liability, Current $28,000 USD 12%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $16,981,000 USD 37%
Operating Lease, Payments $3,000 USD
Depreciation, Depletion and Amortization $4,000 USD 0%
Interest Expense $5,000 USD